Topics
LOBLAW COMPANIES LTD., $175.89, Toronto symbol L, is a buy.
The company operates 1,131 supermarkets under several banners, including Loblaws, Zehrs, Provigo, Real Canadian Superstore and No Frills.
In March 2014, it purchased the Shoppers Drug Mart chain for $12.3 billion in cash and shares....
The company operates 1,131 supermarkets under several banners, including Loblaws, Zehrs, Provigo, Real Canadian Superstore and No Frills.
In March 2014, it purchased the Shoppers Drug Mart chain for $12.3 billion in cash and shares....
You Can See Our Current Power Recommendations For March 2025 Here.
Understanding our recommendations: Power Buy—These stocks are our top choices for new buying now....
The coronavirus pandemic forced the cancellation of most vacation plans. However, the reopening of the economy has spurred strong demand for travel, and both Wyndham and Travel + Leisure should benefit from that continued strength. We see each as a buy.
WYNDHAM HOTELS & RESORTS, $111.77, is a buy. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares outstanding: 77.7 million; Market cap: $8.7 billion; Dividend yield: 1.4%) is the world’s largest hotel franchiser, with 893,000 rooms spread across 9,200 hotels, with 25 brands in 95 countries.
Wyndham Hotels’ revenue in the three months ended December 31, 2024, rose 6.2%, to $341 million from $321 million a year earlier....
WYNDHAM HOTELS & RESORTS, $111.77, is a buy. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares outstanding: 77.7 million; Market cap: $8.7 billion; Dividend yield: 1.4%) is the world’s largest hotel franchiser, with 893,000 rooms spread across 9,200 hotels, with 25 brands in 95 countries.
Wyndham Hotels’ revenue in the three months ended December 31, 2024, rose 6.2%, to $341 million from $321 million a year earlier....
China currently dominates rare-earth production due in part to higher labour costs and tighter environmental restrictions in the U.S. However, politicians and government officials in the U.S. (as well as Canada) are now trying to promote domestic production, and MP Materials continues to benefit from that effort.
MP MATERIALS, $22.99, is still a buy. The company (New York symbol MP; TSINetwork Rating: Extra Risk) (www.mpmaterials.com; Shares o/s: 163.2 million; Market cap: $3.8 billion; No divids.) has commenced commercial production of neodymium-praseodymium (NdPr) metal and trial production of automotive-grade, sintered neodymium-iron-boron (NdFeB) magnets at its flagship Independence facility in Texas.
NdFeB magnets—the world’s most powerful and efficient permanent magnets—are essential components in vehicles, drones, robotics, electronics, and aerospace and defence systems.
Independence is now poised to produce 1,000 metric tons of finished NdFeB magnets per year, with a gradual production ramp-up beginning in late 2025....
MP MATERIALS, $22.99, is still a buy. The company (New York symbol MP; TSINetwork Rating: Extra Risk) (www.mpmaterials.com; Shares o/s: 163.2 million; Market cap: $3.8 billion; No divids.) has commenced commercial production of neodymium-praseodymium (NdPr) metal and trial production of automotive-grade, sintered neodymium-iron-boron (NdFeB) magnets at its flagship Independence facility in Texas.
NdFeB magnets—the world’s most powerful and efficient permanent magnets—are essential components in vehicles, drones, robotics, electronics, and aerospace and defence systems.
Independence is now poised to produce 1,000 metric tons of finished NdFeB magnets per year, with a gradual production ramp-up beginning in late 2025....
Long-time readers know that we aim to keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to bolster investor gains. Here are two buys that stand out this month:
ABBVIE INC., $197.35, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $348.4 billion; Dividend yield: 3.3%) claimed the leading spot last year for TV drug ad spending; specifically, for commercials promoting its immunology blockbusters.
AbbVie’s Skyrizi claimed first place with nearly $377 million spent on 20 separate ads for the drug....
ABBVIE INC., $197.35, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $348.4 billion; Dividend yield: 3.3%) claimed the leading spot last year for TV drug ad spending; specifically, for commercials promoting its immunology blockbusters.
AbbVie’s Skyrizi claimed first place with nearly $377 million spent on 20 separate ads for the drug....
COTERRA ENERGY, $28.69, is a buy. The company (New York symbol CTRA; TSINetwork Rating: Extra Risk) (www.coterra.com; Shares outstanding: 736.4 million; Market cap: $21.1 billion; Dividend yield: 2.9%) and Halliburton Energy Services (symbol HAL on New York) have announced the launch of autonomous hydraulic fracturing technology in North America.
Before this service, fracture decisions were managed manually while pumping....
Before this service, fracture decisions were managed manually while pumping....
The pandemic presented both of these firms with unique challenges. However, each remained profitable and is well positioned to keep prospering as the economy continues to rebound. Trends now underway—as well as the strong position of these firms in key markets—will power their gains....
You should remain wary of stocks that attract broker/media attention because of high-profile products or services, and their business models. Here’s a closer look at one stock with risks that prospective investors should take into consideration:
BROWN-FORMAN CORP., $31.00, (New York symbol BF.B; TSINetwork Rating: Average) (www.brown-forman.com; Shares o/s: 427.7 million; Market cap: $14.7 billion; Dividend yield: 2.9%) makes and sells alcoholic beverages....
BROWN-FORMAN CORP., $31.00, (New York symbol BF.B; TSINetwork Rating: Average) (www.brown-forman.com; Shares o/s: 427.7 million; Market cap: $14.7 billion; Dividend yield: 2.9%) makes and sells alcoholic beverages....
Artificial intelligence (AI) is an example of an investment idea that could boost your investment returns, or, more likely, end up costing you money. All in all, we think that the biggest, surest gains from AI will come from investing in established businesses that are already profitable and growing, and that can gain all the more by applying AI to their operations.
Here are two companies that are already profitably taking advantage of AI, and they should be among the leaders in the push to extend AI’s use:
FAIR ISAAC CORP., $1,755.26, is a buy. The company (New York symbol FICO; TSINetwork Rating: Average) (www.fairisaac.com; Shares outstanding: 24.4 million; Market cap: $42.9 billion; No divd.) is best known for its FICO Scores software....
Here are two companies that are already profitably taking advantage of AI, and they should be among the leaders in the push to extend AI’s use:
FAIR ISAAC CORP., $1,755.26, is a buy. The company (New York symbol FICO; TSINetwork Rating: Average) (www.fairisaac.com; Shares outstanding: 24.4 million; Market cap: $42.9 billion; No divd.) is best known for its FICO Scores software....
ALAMOS GOLD, $32.28, is a buy. The company (Toronto symbol AGI; TSINetwork Rating: Extra Risk) (www.alamosgold.com; Shares o/s: 420.1 million; Market cap: $13.6 billion; Dividend yield: 0.4%) reported gold production of 140,200 ounces in the 2024 fourth quarter, up 8.3% from the third quarter of 2024....